|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein,transferase/inhibitor
|
 |
|
Title:
|
 |
Nmr structure analysis of the hematopoetic cell kinase sh3 domain complexed with an artificial high affinity ligand (pd1)
|
|
Structure:
|
 |
Hematopoetic cell kinase, sh3 domain. Chain: a. Fragment: sh3. Synonym: tyrosine-protein kinase hck. P59-hck/p60-hck. Engineered: yes. Artificial peptide pd1. Chain: b. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: hck. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Synthetic: yes. Other_details: the peptide was identified as high affinity ligand of hck-sh3 from screening a phage displayed peptide libary, acetylated
|
|
NMR struc:
|
 |
20 models
|
 |
|
Authors:
|
 |
H.Schmidt,S.Hoffmann,T.Tran,M.Stoldt,T.Stangler,K.Wiesehan,D.Willbold
|
Key ref:
|
 |
H.Schmidt
et al.
(2007).
Solution structure of a Hck SH3 domain ligand complex reveals novel interaction modes.
J Mol Biol,
365,
1517-1532.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
12-Jan-07
|
Release date:
|
30-Jan-07
|
|
|
Supersedes:
|
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain A:
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
365:1517-1532
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of a Hck SH3 domain ligand complex reveals novel interaction modes.
|
|
H.Schmidt,
S.Hoffmann,
T.Tran,
M.Stoldt,
T.Stangler,
K.Wiesehan,
D.Willbold.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We studied the interaction of hematopoietic cell kinase SH3 domain (HckSH3) with
an artificial 12-residue proline-rich peptide PD1 (HSKYPLPPLPSL) identified as
high affinity ligand (K(D)=0.2 muM). PD1 shows an unusual ligand sequence for
SH3 binding in type I orientation because it lacks the typical basic anchor
residue at position P(-3), but instead has a tyrosine residue at this position.
A basic lysine residue, however, is present at position P(-4). The solution
structure of the HckSH3:PD1 complex, which is the first HckSH3 complex structure
available, clearly reveals that the P(-3) tyrosine residue of PD1 does not take
the position of the typical anchor residue but rather forms additional van der
Waals interactions with the HckSH3 RT loop. Instead, lysine at position P(-4) of
PD1 substitutes the function of the P(-3) anchor residue. This finding expands
the well known ligand consensus sequence +xxPpxP by +xxxPpxP. Thus, software
tools like iSPOT fail to identify PD1 as a high-affinity HckSH3 ligand so far.
In addition, a short antiparallel beta-sheet in the RT loop of HckSH3 is
observed upon PD1 binding. The structure of the HckSH3:PD1 complex reveals novel
features of SH3 ligand binding and yields new insights into the structural
basics of SH3-ligand interactions. Consequences for computational prediction
tools adressing SH3-ligand interactions as well as the biological relevance of
our findings are discussed.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. (a) Ensemble of the 20 lowest energy conformers
calculated for the HckSH3:PD1 complex. The backbone of the
HckSH3 domain is shown in blue, that of the PD1 peptide in
green. For better visualisation of the three-dimensional
character of the conformers, the HckSH3 backbone is coloured by
different gradations. For reasons of clarity, the flexible
residues (60 to 76) of the HckSH3 construct used in the present
study are not represented in the Figure. (b) Ribbon structure of
a representative conformer. For the HckSH3 domain (residues 77
to 140) the elements of secondary structure are labelled. (c)
Surface representation of the chemical shift perturbation
mapping of the HcKSH3 complex with PD1. Red coloured regions
indicate the residues with chemical shift changes Δ[total]δ
≥ 0.2 ppm according to Figure 1(d), orange colour indicates
residues whose resonances could not be identified during the
mapping experiment. Figure 2. (a) Ensemble of the 20 lowest
energy conformers calculated for the HckSH3:PD1 complex. The
backbone of the HckSH3 domain is shown in blue, that of the PD1
peptide in green. For better visualisation of the
three-dimensional character of the conformers, the HckSH3
backbone is coloured by different gradations. For reasons of
clarity, the flexible residues (60 to 76) of the HckSH3
construct used in the present study are not represented in the
Figure. (b) Ribbon structure of a representative conformer. For
the HckSH3 domain (residues 77 to 140) the elements of secondary
structure are labelled. (c) Surface representation of the
chemical shift perturbation mapping of the HcKSH3 complex with
PD1. Red coloured regions indicate the residues with chemical
shift changes Δ[total]δ ≥ 0.2 ppm according to [3]Figure
1(d), orange colour indicates residues whose resonances could
not be identified during the mapping experiment.
|
 |
Figure 4.
Figure 4. (a) Peptide binding region of the HckSH3:PD1 complex.
HckSH3 backbone, hydrophobic and aromatic side-chains are
coloured in blue, charged side-chains of HckSH3 are coloured in
red. PD1 peptide backbone, hydrophobic and aromatic side-chains
are coloured in green and Lys3 is highlighted in purple. Polar
amino acid side-chains of PD1 are coloured in grey. The PD1
amino acid sequence, numbering and SH3 binding positions are
shown below. (b) A focus on the anchor residues binding pocket
shows the positions of the peptide residue Lys3 in different
conformers calculated for the HckSH3:PD1 complex. Side-chains
of different PD1 Lys3 conformers are coloured in purple. The
Lys3 side-chain position upon structure calculation employing
additional constraints describing a salt-bridge between Lys3
and D95 is highlighted in orange. (c) View on the RT loop
regions of the HckSH3:PD1 and the FynSH3:3BP2 (PDB code
1FYN^59) complexes. Superposition is based on optimal fitting of
the C^α coordinates within the β-sheets. The conserved
tryptophan (HckSH3 residue W113) and proline side-chains as well
as the tyrosine side-chain within the 3[10] helix (HckSH3
residue Y131) are coloured in blue and orange for HckSH3 and
FynSH3, respectively. The conserved tryptophan residue in
the FynSH3 complex structure (W119) is known to adopt a SH3-I
orientation.^58 Compared to Fyn W119, the plane of the HckSH3
W113 side-chain is tilted by about 12° towards the conserved
proline residue, indicating a SH3-II orientation for W113 in
the HckSH3:PD1 complex structure. Figure 4. (a) Peptide
binding region of the HckSH3:PD1 complex. HckSH3 backbone,
hydrophobic and aromatic side-chains are coloured in blue,
charged side-chains of HckSH3 are coloured in red. PD1 peptide
backbone, hydrophobic and aromatic side-chains are coloured in
green and Lys3 is highlighted in purple. Polar amino acid
side-chains of PD1 are coloured in grey. The PD1 amino acid
sequence, numbering and SH3 binding positions are shown below.
(b) A focus on the anchor residues binding pocket shows the
positions of the peptide residue Lys3 in different conformers
calculated for the HckSH3:PD1 complex. Side-chains of different
PD1 Lys3 conformers are coloured in purple. The Lys3 side-chain
position upon structure calculation employing additional
constraints describing a salt-bridge between Lys3 and D95 is
highlighted in orange. (c) View on the RT loop regions of the
HckSH3:PD1 and the FynSH3:3BP2 (PDB code 1FYN[3]^59) complexes.
Superposition is based on optimal fitting of the C^α
coordinates within the β-sheets. The conserved tryptophan
(HckSH3 residue W113) and proline side-chains as well as the
tyrosine side-chain within the 3[10] helix (HckSH3 residue Y131)
are coloured in blue and orange for HckSH3 and FynSH3,
respectively. The conserved tryptophan residue in the FynSH3
complex structure (W119) is known to adopt a SH3-I
orientation.[4]^58 Compared to Fyn W119, the plane of the HckSH3
W113 side-chain is tilted by about 12° towards the conserved
proline residue, indicating a SH3-II orientation for W113 in the
HckSH3:PD1 complex structure.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2007,
365,
1517-1532)
copyright 2007.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Jung,
I.J.Byeon,
J.Ahn,
and
A.M.Gronenborn
(2011).
Structure, dynamics, and Hck interaction of full-length HIV-1 Nef.
|
| |
Proteins,
79,
1609-1622.
|
 |
|
|
|
|
 |
R.Batra-Safferling,
J.Granzin,
S.Mödder,
S.Hoffmann,
and
D.Willbold
(2010).
Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding.
|
| |
Biol Chem,
391,
33-42.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Hoffmann,
S.A.Funke,
K.Wiesehan,
S.Moedder,
J.M.Glück,
S.Feuerstein,
M.Gerdts,
J.Mötter,
and
D.Willbold
(2010).
Competitively selected protein ligands pay their increase in specificity by a decrease in affinity.
|
| |
Mol Biosyst,
6,
116-123.
|
 |
|
|
|
|
 |
X.Shi,
S.Opi,
A.Lugari,
A.Restouin,
T.Coursindel,
I.Parrot,
J.Perez,
E.Madore,
P.Zimmermann,
J.Corbeil,
M.Huang,
S.T.Arold,
Y.Collette,
and
X.Morelli
(2010).
Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X.
|
| |
Biochem J,
431,
93.
|
 |
|
|
|
|
 |
I.Dufau,
A.Lazzari,
A.Samson,
I.Pouny,
and
F.Ausseil
(2008).
Optimization of a homogeneous assay for kinase inhibitors in plant extracts.
|
| |
Assay Drug Dev Technol,
6,
673-682.
|
 |
|
|
|
|
 |
T.Stangler,
T.Tran,
S.Hoffmann,
H.Schmidt,
E.Jonas,
and
D.Willbold
(2007).
Competitive displacement of full-length HIV-1 Nef from the Hck SH3 domain by a high-affinity artificial peptide.
|
| |
Biol Chem,
388,
611-615.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |